ProCE Banner Activity

New Data on Pneumococcal Diseases and Vaccines From ESCMID Global 2024 and ISPPD-13

Clinical Thought

Read about new data explaining the burden of pneumococcal diseases, the current and emerging vaccines to reduce this burden, and strategies to increase pneumococcus vaccine coverage of children around the globe.

Released: June 14, 2024

Expiration: June 13, 2025

Share

Faculty

Elisabeth Botelho-Nevers

Elisabeth Botelho-Nevers, MD, PhD, HDR

Full Professor in Infectious Diseases
Head of Infectious Disease Department
University Hospital Saint-Etienne
CIRI Lab, Team GIMAP, Inserm, U1111, CNRS, UMR530
Chair Prevention, Vaccination, Controle de l’infection - PRESAGE
University of Saint-Etienne
Saint-Etienne, France

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Merck & Co., Inc., Rahway, NJ, USA

Disclosure

Primary Author

Elisabeth Botelho-Nevers, MD, PhD, HDR

Full Professor in Infectious Diseases
Head of Infectious Disease Department
University Hospital Saint-Etienne
CIRI Lab, Team GIMAP, Inserm, U1111, CNRS, UMR530
Chair Prevention, Vaccination, Controle de l’infection - PRESAGE
University of Saint-Etienne
Saint-Etienne, France

Elisabeth Botelho-Nevers, MD, PhD, HDR: consultant/advisor/speaker: GlaxoSmithKline, Merck Sharp & Dohme, Moderna, Pfizer, Sanofi Pasteur; researcher: GlaxoSmithKline, Janssen, Merck Sharp & Dohme, Moderna, Pfizer, Sanofi Pasteur.